Prosight Management, LP Medtronic PLC Transaction History

Prosight Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $11.8 Million - $13.1 Million	-150,000 Reduced 83.33%	30,000 $2.36 Million
Q1 2024 May 15, 2024	SELL	$82.84 - $88.09 $3.31 Million - $3.52 Million	-40,000 Reduced 18.18%	180,000 $15.7 Million
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $4.86 Million - $5.84 Million	70,000 Added 46.67%	220,000 $18.1 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $7.04 Million - $8.14 Million	90,000 Added 150.0%	150,000 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$79.47 - $91.38 $4.77 Million - $5.48 Million	60,000 New	60,000 $5.29 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $1.35 Million - $1.49 Million	-11,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $1.07 Million - $1.2 Million	-9,088 Reduced 45.24%	11,000 $1.37 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $2.23 Million - $2.41 Million	20,088 New	20,088 $2.37 Million

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.